PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round
New funding includes €11.8M in equity and €5.7M in grants. It completes the €20M B1 round of financing announced in January 2020Proceeds will primarily be used to fund company’s phase I/II trial with PDC*lung01, a vaccine candidate for…